cyc 202 has been researched along with Carcinoma, Anaplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajek, SB; Kramer, MP; Krystof, V; Pickem, C; Wandl, S; Wesierska-Gadek, J | 1 |
| Alfano, S; Festa, M; Parente, L; Petrella, A | 1 |
| Chen, MJ; Hsu, JM; Kan, SF; Pu, HF; Wang, PS; Yu, CH | 1 |
| David-Pfeuty, T | 1 |
4 other study(ies) available for cyc 202 and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Roscovitine up-regulates p53 protein and induces apoptosis in human HeLaS(3) cervix carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Survival; Female; HeLa Cells; Humans; Purines; Roscovitine; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2008 |
R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; bcl-X Protein; Carcinoma; Caspase 3; Cell Division; Cell Line, Tumor; G2 Phase; Humans; I-kappa B Kinase; NF-kappa B; Purines; Receptors, TNF-Related Apoptosis-Inducing Ligand; Roscovitine; Signal Transduction; Thyroid Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2009 |
Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3.
Topics: Androgens; Apoptosis; Carcinoma; Caspase 3; Caspase 8; Caspase 9; CDC2 Protein Kinase; Cell Division; Cell Line, Tumor; Culture Media; Cyclin B; Cyclin B1; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; G2 Phase; Humans; L-Lactate Dehydrogenase; Male; Plant Extracts; Prostatic Neoplasms; Purines; Quinazolines; Roscovitine | 2007 |
Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
Topics: Blotting, Western; Breast Neoplasms; Carcinoma; CDC2-CDC28 Kinases; Cell Cycle; Cell Death; Cell Line; Cell Line, Transformed; Cell Nucleolus; Cell Nucleus; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Inhibitors; G1 Phase; Humans; Inhibitory Concentration 50; Kinetin; Mitomycin; Nucleic Acid Synthesis Inhibitors; Nucleolin; Phosphoproteins; Protein Serine-Threonine Kinases; Purines; RNA-Binding Proteins; Roscovitine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |